See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516551_2017_Skye_Bioscience_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001516551')"} |
Graph
Absolute values for 0001516551, Skye Bioscience Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 279,489 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 9,584 |
3 | remainder_Assets | 34,290 |
4 | LiabilitiesCurrent | 661,958 |
5 | LiabilitiesNoncurrent | 1,112,308 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 3,531,540 |
9 | ResearchAndDevelopmentExpense | 939,040 |
10 | remainder_Expenses | -1,341,051 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 323,363 |
1 | Liabilities | 1,774,266 |
2 | Expenses | 3,129,529 |
3 | Revenues | 0 |
4 | StockholdersEquity | -1,450,903 |
5 | NetIncome | -3,129,529 |
6 | ComprehensiveNetIncome | -3,129,529 |
7 | BaseVar | 2,613,579 |
8 | EconomicCapitalRatio | -5.36 |